Navigation Links
Pelosi: 'Genetic Information Nondiscrimination Act Will Protect Americans from Misuse of Genetic Information'
Date:5/1/2008

WASHINGTON, May 1 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi today released the following statement in support of the Genetic Information Nondiscrimination Act, which the House passed this afternoon by an overwhelming 414 to 1 vote. The landmark bill, which would prohibit health insurance companies and employers from discriminating against people on the basis of genetic test results, now goes to the President's desk for his signature. Below are the Speaker's remarks, which will be inserted into the Congressional Record:

"Mr. Speaker, I rise today in strong support of the Genetic Information Nondiscrimination Act.

"I would like to thank Congresswoman Louise Slaughter for her outstanding leadership on this issue. For 13 years, she has worked to pass this bill to protect Americans from genetic discrimination. She's both the powerful chair of the Rules Committee, and a microbiologist, so she knows what she is talking about.

"The sequencing of the human genetic code is one of the great scientific accomplishments in the history of the world. It has the potential to treat and prevent disease. It is evidence of science's almost-biblical power to heal.

"But with this scientific breakthrough comes a responsibility to protect Americans from the misuse of their genetic information. Today, the Congress will begin to fulfill that responsibility by passing this legislation.

"This legislation prevents health insurers from adverse coverage or pricing decisions based on a person's genetic predisposition toward a disease. It ensures an employer cannot make adverse employment decisions based on what is in a person's genetic code. It also makes it illegal for an insurer or employer to request or demand a gene test.

"Because of this legislation, Americans will be free to undergo genetic testing for diseases such as cancer, heart disease, diabetes, and Alzheimer's, without fearing for their job or health insurance. There is life-saving information in those tests. And for scientists, there is information that allows for huge breakthroughs.

"This legislation is supported by the vast majority of the American people, 93 percent of whom do not want employers to have access to their genetic information.

"This is such good policy that this legislation is supported by more than 500 organizations, including a broad coalition of civil rights and religious organizations. Health advocacy groups ranging from the American Academy of Pediatrics to the March of Dimes to the Susan G. Komen Breast Cancer Foundation have endorsed it.

"In the Congress, it has broad bipartisan support. It also has the support of the President.

"Mr. Speaker, let us not wait another day to pass this legislation so it can move to the President's desk for his signature and become law."


'/>"/>
SOURCE Office of the Speaker of the House
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pelosi: By Literally Fixing Broken Hearts, Dr. DeBakey Has Given Hope and Health to Millions
2. Pelosi: President Bushs Proposed Medicare and Medicaid Cuts Are Exactly the Wrong Medicine
3. Pelosi: We Will Keep Fighting Next Year to Cover 10 Million Children and Improve Benefits for Low-Income Seniors
4. Pelosi: In 48 Hours, Congress Must Choose Between Meeting the Needs of Americas Children or Not
5. Pelosi: This Week, Members Must Choose Between Partisan Obstruction and Health Insurance for 10 Million Children
6. Pelosi: We Remain Committed to Making SCHIP Into Law - With or Without the Presidents Support
7. Pelosi: Tonights Strong Bipartisan Vote for Childrens Health Insurance a Victory for Americas Children
8. Pelosi: Mr. President - Drop the Partisan Rhetoric, Put Down the Veto Pen
9. Pelosi: Todays Sweeping, Bipartisan Legislation to Improve Drug Safety is a Victory for All Americans
10. Pelosi: SCHIP Bill a Giant Step for Americas Children
11. Genetic Changes May Dictate Course of Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... rising prescription opioid overdose deaths now claim the lives of 62 Americans each ... case filings against drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of ... News website. , Rod has been at the forefront of Gardant since it was ... CEO, Rod has overseen the opening of more than 40 new senior living communities. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on ... Blvd, for an educational and exciting 2-day program. , An attendee at a ... before they approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... that over the last decade, student well-being has seriously declined. "When disenfranchised youth ... formal education, join the Islamic State to turn the historic multi-ethnic and multi-religious ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, and Omega ... Omega Station” is the creation of published author, Chris Jackson. Chris Jackson grew ... works in the Dallas Independent School District teaching English. He is heavily involved in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: